I think the only product or a large part of our sales at the...

I think the only product or a large part of our sales at the moment are the Access Bio RATs.

Atomo may have already fulfilled their supply obligations in regards to the Mylan/Viatris & Unitaid contract,
not sure if they are supplying anymore.

No more anti-body test kits to NG Biotech/Access Bio.

OEM sales to Lumos seem slim, First HY 2022 value was $0.00

I note some posters here ( i think Finfree) were able to upload international shipping dockets(or similar) , showing
what Atomo was exporting and to who, however nothing on that side lately as well.

So really, the income is primarily being generated by the resale of the Access Bio RATs, I think
they deserve a mention.